Answers are grounded in this paper and cite their sources.
Tibetan dark tea (TT) has potential benefits for intestinal health, but the mechanisms underlying its effects on ulcerative colitis (UC) and remain unclear. Here, we characterized the major constituents of TT and evaluated its bioactivity in LPS-stimulated RAW 264.7 macrophages, a dextran sulfate sodium (DSS)-induced mouse model of colitis, and ferroptosis models in colonic epithelial cells. TT administration alleviated body weight loss, hematochezia, colon shortening, systemic inflammation, and tissue injury in DSS-treated mice. Mechanistically, TT suppressed NF-κB activation, enhanced Nrf2-mediated antioxidant defenses, restored iron homeostasis, and attenuated ferroptosis. Further mechanistic validation identified thioredoxin reductase (TXNRD) as a key mediator of the protective effects of TT against ferroptotic injury. TT also reshaped the gut microbiota, as characterized by an increased abundance of Akkermansia , and partially restored metabolic disturbances involving tryptophan, caffeine, flavonoids, and linoleic acid. Collectively, these findings indicate that TT ameliorates UC by coordinately suppressing inflammation and TXNRD-regulated ferroptosis while remodeling the gut microbiota-metabolite axis, supporting its potential as a functional dietary strategy for intestinal health.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: